> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Quidel Cardio Recalls Cardiac Panel Test
- URL: https://www.fdaweb.com/quidel-cardio-recalls-cardiac-panel-test/
- Published: 2023-07-17T12:00:00.000Z
- Updated: 2026-09-14T18:44:37.000Z
- Author: David McFarland
- Tags: Devices, #legacy-id-D5154887

Quidel Cardiovascular has recalled (Class 1) the Quidel Triage Cardiac Panel after reports of inaccurate tests showing lower-than-expected troponin levels in samples. “A falsely low or false negative troponin level may cause a delayed or missed diagnosis of myocardial infarction — a serious, potentially fatal condition that requires the earliest detection possible to treat and protect the heart muscle effectively,” a [recall notice](https://www.fda.gov/medical-devices/medical-device-recalls/quidel-cardiovascular-inc-recalls-quidel-triage-cardiac-panels-risk-false-negative-troponin-results?ref=fdaweb.com) says. This could present a greater risk to people who “experience a silent myocardial infarction with no other symptoms, those who have unusual or atypical symptoms, and those with non-ST-segment elevation myocardial infarction (NSTEMI),” it says. To date, the notice says the company has received 41 complaints, no injuries, and no deaths related to the issue.